ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tanshinone IIA regulates the TGF-β1/Smad signaling pathway to ameliorate non-alcoholic steatohepatitis-related fibrosis

Xu, Lianjie; Zhang, Yurong; Ji, Nengbo; Du, Yan; Jia, Tao; Wei, Shanshan; Wang, Wei; Zhang, Shan*; Chen, Wenhui*1
Experimental and Therapeutic Medicine2022-7DOI: 10.3892/etm.2022.11413
3被引14阅读
引用收藏
分享

摘要

Tanshinone IIA (TIIA) is a major component extracted from the traditional herbal medicine Salvia miltiorrhiza and has been indicated to play a role in the treatment of organ fibrosis. However, the evidence supporting its antifibrotic effect is insufficient and the underlying mechanism is unclear. To investigate the therapeutic effect of TIIA on non-alcoholic steatohepatitis-related fibrosis (NASH-F), the present study used a methionine choline deficiency diet to induce NASH-F in rats, and explored the effect of TIIA on the transforming growth factor-beta 1 (TGF-beta 1)/Smad signaling pathway. Wistar rats were randomly divided into control, NASH-F and TIIA groups. After 8 weeks of treatment, the levels of serum markers associated with liver function and fibrosis were measured, liver fat vacuoles and inflammation were assessed by haematoxylin and eosin staining, and liver fibrosis was assessed by Masson's trichrome staining. TGF-beta 1, Smad2, Smad3, Smad7 and alpha-smooth muscle actin (alpha-SMA) mRNA expression, and TGF-beta 1, Smad2/3, phosphorylated (p)-Smad2/3, Smad7 and alpha-SMA protein levels were determined. The results revealed that TIIA could remarkably ameliorate liver fat vacuoles and inflammation in NASH-F rats, and could decrease the levels of serum aspartate aminotransferase, alanine aminotransferase, total bilirubin, total bile acid, hyaluronic acid, type IV collagen, laminin and type III collagen, while increasing the levels of total cholesterol and triglycerides; however, this was not statistically significance. TIIA markedly suppressed the increased TGF-beta 1, Smad2, Smad3 and alpha-SMA mRNA expression levels observed in the liver of NASH-F rats, while it increased the mRNA expression level of Smad7. Similarly, TIIA suppressed the increased TGF-beta 1, p-Smad2/3 and alpha-SMA protein levels observed in the liver of NASH-F rats, while it increased the protein expression level of Smad7 in vitro and in vivo. TIIA had no significant cytotoxic effect at 10, 20, 40 and 80 mu mol/l on human LX-2 cell. In conclusion, the findings of the present study indicated that TIIA alleviated NASH-F by regulating the TGF-beta 1/Smad signaling pathway. TIIA may be a useful tool in the prevention and treatment of NASH-F.

学科与关键词

关键词
hepatic fibrosisnon-alcoholic steatohepatitistanshinone IIATGF-beta 1/Smad
相关
加载中…
  • Tanshinone IIA Ameliorates Nonalcoholic Steatohepatitis in Mice by Modulating Neutrophil Extracellular Traps and Hepatocyte Apoptosis
    Xu, Lianjie; Liu, Xiao; Jia, Tao; Sun, Yanhong; Du, Yan; Wei, Shanshan; Wang, Wei; Zhang, Yurong; Chen, Wenhui; Zhang, Shan*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 5769350.被引 6
  • Tanshinone IIA Regulates Keap1/Nrf2 Signal Pathway by Activating Sestrin2 to Restrain Pulmonary Fibrosis
    Li, Hongxia; Wu, Mingyu; Guo, Congying; Zhai, Rao; Chen, Jun*AMERICAN JOURNAL OF CHINESE MEDICINE, 2022, 50(8): 2125-2151.被引 14
  • Aloin Attenuates Oxidative Stress, Inflammation, and CCl4-Induced Liver Fibrosis in Mice: Possible Role of TGF-β/Smad Signaling
    Bai, Junjie; Qian, Baolin; Cai, Tianying; Chen, Yifan; Li, Tongxi; Cheng, Yonglang; Wu, Ziming; Liu, Chen; Ye, Mingxin*; Du, Yichao*; Fu, Wenguang*Journal of Agricultural and Food Chemistry, 2023, 71(49): 19475-19487.
查看全部 →

发表信息

论文状态
公开发表
期刊
Experimental and Therapeutic Medicine
发表日期
2022-07
卷期
第 24 卷, 第 1 期
DOI
10.3892/etm.2022.11413
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81960814, 81760818, 82160898]; Science andTechnology Program of Yunnan Science and Technology Department [2018FF001(-006), 2019FF002(-079), 202101AZ070001-042]; Yunnan Provincial Key Laboratory of Molecular Biology for Sinomedicine (Yunnan University of Traditional Chinese Medicine) [2019DG016]

作者

  • X

    Xu, Lianjie (第一作者)

    yunnan univ tradit chinese med

  • Z

    Zhang, Yurong

    yunnan univ tradit chinese med

查看全部 9 位作者收起作者
  • J

    Ji, Nengbo

    yunnan univ tradit chinese med

  • D

    Du, Yan

    yunnan univ tradit chinese med

  • J

    Jia, Tao

    1 · yunnan univ tradit chinese med

  • W

    Wei, Shanshan

    yunnan univ tradit chinese med

  • W

    Wang, Wei

    yunnan univ tradit chinese med

  • Z

    Zhang, Shan (通讯)

    yunnan univ tradit chinese med

  • C

    Chen, Wenhui (通讯)

    yunnan univ tradit chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417